Back to Royal Bank of Canada Royal Bank of Canada

IBIO

9 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in iBio, Inc.

No. Royal Bank of Canada exited its IBIO position in Q2 2026. Its Q1 2026 13F listed 3,891 shares worth $7,000. Royal Bank of Canada first reported IBIO in Q4 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

-78

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.75
0
2026-Q1
New
3,891
-
$7,0000.0%$1.90
25
2025-Q2
Exited
0
-100.0%
$00.0%$0.76
0
2025-Q1
Increased
1,000
+124x
$4,0000.0%$4.02
16
2024-Q4
Unchanged
8
0.0%
$00.0%$2.45
0
2024-Q3
Decreased
8
-78.4%
$00.0%$2.22
0
2024-Q2
Decreased
37
-28.9%
$00.0%$2.11
0
2024-Q1
Decreased
52
-33.3%
$00.0%$4.06
0
2023-Q4
New
78
-
$00.0%$1.37
17

Other major holders of IBIO: Vanguard Capital Management LLC, Ensign Peak Advisors, Inc, Woodline Partners LP, Millennium Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used